WO2008007224A3 - Foamable suspension gel - Google Patents

Foamable suspension gel Download PDF

Info

Publication number
WO2008007224A3
WO2008007224A3 PCT/IB2007/002958 IB2007002958W WO2008007224A3 WO 2008007224 A3 WO2008007224 A3 WO 2008007224A3 IB 2007002958 W IB2007002958 W IB 2007002958W WO 2008007224 A3 WO2008007224 A3 WO 2008007224A3
Authority
WO
WIPO (PCT)
Prior art keywords
foamable suspension
active agent
suspension gel
pharmaceutically active
suspension gels
Prior art date
Application number
PCT/IB2007/002958
Other languages
French (fr)
Other versions
WO2008007224A2 (en
Inventor
Albert Zorko Abram
Lilian Fuchshuber
Original Assignee
Connetics Australia Pty Ltd
Albert Zorko Abram
Lilian Fuchshuber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38923603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2008007224(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Connetics Australia Pty Ltd, Albert Zorko Abram, Lilian Fuchshuber filed Critical Connetics Australia Pty Ltd
Priority to KR1020087026472A priority Critical patent/KR101368107B1/en
Priority to EP07825280.6A priority patent/EP2010133B1/en
Priority to ES07825280.6T priority patent/ES2582654T3/en
Priority to BRPI0709674-7A priority patent/BRPI0709674A2/en
Priority to MX2008012526A priority patent/MX2008012526A/en
Priority to AU2007273935A priority patent/AU2007273935B2/en
Priority to CA2647127A priority patent/CA2647127C/en
Publication of WO2008007224A2 publication Critical patent/WO2008007224A2/en
Publication of WO2008007224A3 publication Critical patent/WO2008007224A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Abstract

The present subject matter provides foamable suspension gels that foam after release from a container. The foamable suspension gels contain at least one pharmaceutically active agent that is sparingly soluble to insoluble in water, a second pharmaceutically active agent, and optionally a third active agent.
PCT/IB2007/002958 2006-03-31 2007-03-29 Foamable suspension gel WO2008007224A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
KR1020087026472A KR101368107B1 (en) 2006-03-31 2007-03-29 Foamable suspension gel
EP07825280.6A EP2010133B1 (en) 2006-03-31 2007-03-29 Foamable suspension gel
ES07825280.6T ES2582654T3 (en) 2006-03-31 2007-03-29 Foamable suspension gel
BRPI0709674-7A BRPI0709674A2 (en) 2006-03-31 2007-03-29 sparkling suspension gel
MX2008012526A MX2008012526A (en) 2006-03-31 2007-03-29 Foamable suspension gel.
AU2007273935A AU2007273935B2 (en) 2006-03-31 2007-03-29 Foamable suspension gel
CA2647127A CA2647127C (en) 2006-03-31 2007-03-29 Foamable suspension gel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74408206P 2006-03-31 2006-03-31
US60/744,082 2006-03-31

Publications (2)

Publication Number Publication Date
WO2008007224A2 WO2008007224A2 (en) 2008-01-17
WO2008007224A3 true WO2008007224A3 (en) 2008-04-17

Family

ID=38923603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002958 WO2008007224A2 (en) 2006-03-31 2007-03-29 Foamable suspension gel

Country Status (12)

Country Link
US (4) US8158109B2 (en)
EP (2) EP2206494B1 (en)
KR (1) KR101368107B1 (en)
AR (1) AR060234A1 (en)
AU (1) AU2007273935B2 (en)
BR (1) BRPI0709674A2 (en)
CA (1) CA2647127C (en)
ES (2) ES2582654T3 (en)
MX (1) MX2008012526A (en)
PL (2) PL2206494T3 (en)
TW (1) TWI442944B (en)
WO (1) WO2008007224A2 (en)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
CA2513773C (en) * 2003-01-24 2013-03-26 Connetics Australia Pty Ltd Clindamycin phosphate foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
JP2005310310A (en) * 2004-04-23 2005-11-04 Sanyo Electric Co Ltd Tracking balance adjustment device
EP2526930B1 (en) 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
MX2008012526A (en) 2006-03-31 2008-10-14 Stiefel Res Australia Pyt Ltd Foamable suspension gel.
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2910320B1 (en) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
FR2910321B1 (en) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
EP2214661A4 (en) * 2007-10-18 2012-10-03 Medicis Pharmaceutical Corp Aqueous retinoid and benzoyl peroxide gel
WO2009069006A2 (en) * 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
MX2010013152A (en) 2008-06-05 2011-05-02 Dow Pharmaceutical Sciences Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent.
EP2395994A4 (en) * 2009-02-12 2013-05-22 Prec Dermatology Inc Foamable benzoyl peroxide compositions for topical administration
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776474C (en) 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
KR101253388B1 (en) 2009-11-30 2013-04-11 (주)아모레퍼시픽 Improved stability Composition for controlling anti-acne
WO2011119585A2 (en) * 2010-03-26 2011-09-29 Precision Dermatology, Inc. Aerosol foams comprising clindamycin phosphate
US8802058B2 (en) 2010-04-19 2014-08-12 Gelmed, Llc Pharmaceutical compositions and methods for administering the same
FR2969492B1 (en) 2010-12-23 2013-07-05 Galderma Res & Dev DERMATOLOGICAL FOAMS OBTAINED FROM GEL OR SUSPENSION CONTAINING ADAPALENE
FR2969493B1 (en) * 2010-12-23 2013-07-05 Galderma Res & Dev DERMATOLOGICAL FOAMS OBTAINED FROM GEL OR SUSPENSION CONTAINING BPO
FR2969491B1 (en) * 2010-12-23 2013-07-12 Galderma Res & Dev DERMATOLOGICAL FOAMS OBTAINED FROM GEL OR SUSPENSION CONTAINING A COMBINATION OF ADAPALENE AND BPO
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis
CN106456544B (en) * 2014-03-28 2021-02-02 盖尔德马研究及发展公司 Leave-on chemical foam comprising adapalene and benzoyl peroxide
JP2017508762A (en) 2014-03-28 2017-03-30 ガルデルマ・リサーチ・アンド・デヴェロップメント Sootless chemical mousse containing benzoyl peroxide
BR112016022340A2 (en) 2014-03-28 2017-08-15 Galderma Res & Dev COMPOSITION, COSMETIC USE OF A COMPOSITION, DRUG AND KIT
US10358625B2 (en) 2015-07-17 2019-07-23 S. C. Johnson & Son, Inc. Non-corrosive cleaning composition
US10000728B2 (en) * 2015-07-17 2018-06-19 S. C. Johnson & Son, Inc. Cleaning composition with propellant
US10604724B2 (en) 2015-08-27 2020-03-31 S. C. Johnson & Son, Inc. Cleaning gel with glycine betaine amide/nonionic surfactant mixture
WO2017034792A1 (en) 2015-08-27 2017-03-02 S. C. Johnson & Son, Inc. Cleaning gel with glycine betaine ester
FR3041539B1 (en) 2015-09-29 2018-10-26 Galderma Research & Development SELF-FOAMING CLEANING COMPOSITION CONTAINING CLOBETASOL PROPIONATE AND USE THEREOF IN THE TREATMENT OF PSORIASIS
FR3041541B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development NON-RINSE CHEMICAL FOAM COMPRISING IVERMECTIN
FR3041535B1 (en) 2015-09-29 2019-01-25 Galderma Research & Development NON-RINSE CHEMICAL FOAM CONTAINING TRIFAROTENE AND USE THEREOF IN THE TREATMENT OF ICHTYOSE
FR3041538B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development NON-RINSE CHEMICAL FOAM CONTAINING CLOBETASOL PROPIONATE AND USE THEREOF IN THE TREATMENT OF PSORIASIS
FR3041537B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development BRIMONIDINE CONTAINING CHEMICAL FOAM WITHOUT RINSE AND USE THEREOF FOR TREATING ROSACEA.
FR3041536B1 (en) 2015-09-29 2018-11-30 Galderma Research & Development NON-RINSEED CHEMICAL FOAM CONTAINING TRIFAROTENE AND USE THEREOF IN THE TREATMENT OF ACNE
CN108348456B (en) 2015-10-30 2021-09-17 亭铂医药有限责任公司 Isotretinoin formulations and uses and methods thereof
WO2017099933A1 (en) 2015-12-07 2017-06-15 S.C. Johnson & Son, Inc. Acidic hard surface cleaner with glycine betaine ester
WO2017099932A1 (en) 2015-12-07 2017-06-15 S.C. Johnson & Son, Inc. Acidic hard surface cleaner with glycine betaine amide
BR112018073084B1 (en) 2016-05-11 2022-09-13 Formulated Solutions, Llc FORMULATION AND PRESSURIZED PACKAGING
MX2018013757A (en) * 2016-05-11 2019-09-09 Bayer Healthcare Llc Thermal-stable whipped formulations.
CN107541735B (en) * 2016-06-24 2022-01-21 三星显示有限公司 Cleaning composition for removing oxides and cleaning method using the same
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
CN110913849A (en) * 2017-03-30 2020-03-24 科学派有限责任公司 Methods of treating and preventing infections
EP3651755A4 (en) * 2017-07-12 2021-03-24 Sol-Gel Technologies Ltd. Methods and compositions for the treatment of acne
GB201917469D0 (en) * 2019-11-29 2020-01-15 Nicoventures Trading Ltd Aerosol generation
AU2022318739A1 (en) * 2021-07-26 2024-02-15 Daré Bioscience, Inc. Compositions for use in the treatment of bacterial vaginosis
AU2022319690A1 (en) * 2021-07-26 2024-03-14 Dare Bioscience, Inc. Compositions for use in the treatment of dysmenorrhea

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045662A2 (en) * 2000-12-06 2002-06-13 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US20040073946A1 (en) * 2002-10-01 2004-04-15 Yoshikazu Kobayashi Terminal device, method for processing communication data inside the terminal device, and program for implementing the method
US20040151671A1 (en) * 2003-01-24 2004-08-05 Connetics Australia Pty Ltd. Pharmaceutical foam
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter

Family Cites Families (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487068A (en) 1966-12-16 1969-12-30 Upjohn Co Lincomycin-2-phosphates,7-substituted compounds and salts thereof
US3475407A (en) 1967-12-22 1969-10-28 Upjohn Co Process for preparing 7(r)- and 7(s)-halolincomycins
US3509127A (en) 1968-04-30 1970-04-28 Upjohn Co Isologs of lincomycins and process for preparing the same
US3544551A (en) 1968-04-30 1970-12-01 Upjohn Co 7-mercapto-7-deoxylincomycins and process for preparing the same
US3513155A (en) 1968-05-07 1970-05-19 Upjohn Co Sulfoxides of 7-halo-7-deoxylincomycins and process
US3580904A (en) 1969-04-03 1971-05-25 Upjohn Co 7-halo-7-deoxy-lincomycin derivatives
US3714141A (en) 1970-05-26 1973-01-30 Upjohn Co Process for making 7-halolincomycins
US3655885A (en) 1970-06-10 1972-04-11 Upjohn Co Antibacterial compositions and methods of treating bacterial infections
US3952099A (en) 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US3906108A (en) 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US3969516A (en) 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4497794A (en) 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4505896A (en) 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4387107A (en) 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
US4443442A (en) 1979-12-21 1984-04-17 Skillern Scott D Method and composition for treatment of acne vulgaris
US4692329A (en) 1980-12-08 1987-09-08 William H. Rorer, Inc. Erythromycin/benzoyl peroxide antiacne compositions
ATE71295T1 (en) 1983-10-24 1992-01-15 Lockley Services Pty Ltd FOAMABLE BIOCIDE COMPOSITION.
LU85111A1 (en) 1983-12-01 1985-09-12 Oreal ANTI-ACNETIC COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE SOLAR FILTER
US4568741A (en) 1984-05-15 1986-02-04 The Upjohn Company Synthesis of 7-halo-7-deoxylincomycins
US4609674A (en) 1984-06-11 1986-09-02 Richardson-Vicks Inc. Stabilized clear benzoyl peroxide compositions
EP0190158A1 (en) 1984-06-21 1986-08-13 Soltec Research Pty. Ltd. Aerosol product
CN1004002B (en) 1984-11-29 1989-04-26 厄普约翰公司 Improving one's methods of preparation 7-halogen-7-deoxy-lincomycin and similar compound thereof
US5086075A (en) 1985-01-24 1992-02-04 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US4731362A (en) 1985-08-05 1988-03-15 Shionogi & Co., Ltd. Alkylcarbamoyloxymethylcephem compounds
US4806262A (en) 1985-08-14 1989-02-21 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US5446028A (en) 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US5316759A (en) 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
FR2604357B1 (en) 1986-09-30 1988-12-02 Oreal PHARMACEUTICAL AND ANTI-ACNE COSMETIC COMPOSITION
FR2604435B1 (en) 1986-09-30 1988-12-02 Oreal UNSATURATED AROMATIC PEROXIDES AND THEIR USE IN THERAPEUTICS AND COSMETICS
US4882182A (en) 1987-01-08 1989-11-21 Soltec Research Pty. Ltd. Aerosol product
US5811088A (en) 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US5089509A (en) 1988-09-15 1992-02-18 Allergan, Inc. Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
US5602130A (en) 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
FR2623395B1 (en) 1987-11-24 1990-04-20 Oreal PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON BENZOYL PEROXIDE AND QUATERNARY AMMONIUM LIPOPHILIC SALICYLATES AND THEIR USE, ESPECIALLY IN THE TREATMENT OF ACNE
AU619256B2 (en) 1988-03-03 1992-01-23 Connetics Australia Pty Ltd Acne treatment
FR2628319B1 (en) 1988-03-09 1990-12-07 Oreal PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON BENZOYL PEROXIDE AND QUATERNARY AMMONIUM SALTS
WO1990011068A1 (en) 1989-03-17 1990-10-04 Taisho Pharmaceutical Co., Ltd. Aerosol preparation for external use
US5204093A (en) 1989-04-06 1993-04-20 Victor Steven A Shaving cream composition for the treatment of acne vulgaris and pseudofolliculitis barbae and method of producing and using same
CA2063576C (en) 1989-06-07 1994-01-25 Gail S. Bazzano Slow release vehicles for minimizing skin irritancy of topical compositions
AU629670B2 (en) 1989-07-28 1992-10-08 Hisamitsu Pharmaceutical Co., Inc. Foamed aerosol preparation
EP1070752A3 (en) 1990-09-03 2003-08-27 Connetics Australia Pty Limited A concentrated aerosol space spray
US5935554A (en) 1990-09-03 1999-08-10 Soltec Research Pty. Ltd. Concentrated aerosol space spray that is not an emulsion
ATE162725T1 (en) 1991-10-16 1998-02-15 Richardson Vicks Inc IMPROVED SKIN PENETRATION SYSTEMS FOR INCREASED TOPICAL RELEASE OF DRUGS
JP3555762B2 (en) 1991-10-16 2004-08-18 リチャードソン、ビックス、インコーポレーテッド Low pH aqueous cosmetic gel containing nonionic polyacrylamide derivative
TW203552B (en) 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6117843A (en) 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
IL105217A0 (en) 1992-04-09 1993-07-08 Allergan Inc Method and composition for treating acne
US5254109A (en) 1992-12-07 1993-10-19 Creative Products Resource Associates, Ltd. Separately packaged applicator pads for topical delivery of incompatable drugs
US5635469A (en) 1993-06-10 1997-06-03 The Procter & Gamble Company Foaming cleansing products
CA2166062C (en) 1993-07-01 2008-09-16 Tom De Vringer The use of non-ionic surfactants in stable topical retinoid compositions
FR2710840B1 (en) 1993-10-04 1995-12-01 Applic Transferts Technolo Viscoelastic compositions highly concentrated in fluorinated compounds, their preparation and their uses in the medical and cosmetic fields.
US5466446A (en) 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US6001380A (en) 1994-04-12 1999-12-14 Creative Products Resource, Inc. Medicated applicator sheet for topical drug delivery
US5470884A (en) 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
ZA954599B (en) 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
US5679324A (en) * 1994-07-08 1997-10-21 The Procter & Gamble Co. Aerosol foamable fragrance composition
FR2722102B1 (en) 1994-07-11 1996-08-23 Cird Galderma USE OF DEFORMABLE HOLLOW PARTICLES IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING FAT MATERIALS
FR2722691A1 (en) 1994-07-22 1996-01-26 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTENT COMBATING ACNE OR AGING WITH THERMAL OR MINERAL WATER AND AN ACTIVE INGREDIENT FOR
US5449519C1 (en) 1994-08-09 2001-05-01 Revlon Consumer Prod Corp Cosmetic compositions having keratolytic and anti-acne activity
US5776430A (en) 1994-11-01 1998-07-07 Calgon Vestal, Inc. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
US5716625A (en) 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5756107A (en) 1994-12-21 1998-05-26 Cosmederm Technologies Formulations and methods for reducing skin irritation
US6139850A (en) 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5618850A (en) 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
US5783202A (en) 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
AT408067B (en) 1995-03-17 2001-08-27 Gebro Pharma Gmbh PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION AND METHOD FOR THE PRODUCTION THEREOF
US5948416A (en) 1995-06-29 1999-09-07 The Procter & Gamble Company Stable topical compositions
US5621008A (en) 1995-10-27 1997-04-15 Avon Products, Inc. N-acyl-ethylene-triacetic acids
US5648389A (en) 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use
FR2740685B1 (en) 1995-11-08 1998-01-23 Pf Medicament TOPICAL FOAMING PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DERMATOSIS, INDUCED BY OVAL PITYROSPORUM
US5958436A (en) 1995-12-21 1999-09-28 Cosmederm Technologies Formulations and methods for reducing skin irritation
AR006049A1 (en) 1996-03-01 1999-07-21 Johnson & Johnson Consumer AN EMULSION OF OIL IN WATER
US5998392A (en) 1996-04-10 1999-12-07 Gattefosse S.A. Benzoyl peroxide flocculent materials and methods of their preparation
GR1002807B (en) 1996-06-20 1997-11-13 Lavipharm A.E. Device for topical treatment of acne and method of manufacture.
US5788155A (en) 1996-06-28 1998-08-04 S. C. Johnson & Son, Inc. Air freshener dispenser device with dual cartridge capacity
US5993787A (en) 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US5843881A (en) 1997-02-13 1998-12-01 The Procter & Gamble Company Spray compositions
US5935596A (en) 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
AUPO688997A0 (en) 1997-05-20 1997-06-12 Soltec Research Pty Ltd Sunscreen composition
CN1133422C (en) 1997-07-08 2004-01-07 科斯莫弗姆有限公司 Topical application of combination of benzoyl peroxide and second active ingredient
US6017549A (en) 1997-09-30 2000-01-25 E-L Management Corp. Non-irritating cosmetic and pharmaceutical compositions
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
US6013637A (en) 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
US6017938A (en) 1998-07-28 2000-01-25 Bershad; Susan Short contact treatment for acne
ATE347885T1 (en) 1998-07-28 2007-01-15 Susan Bershad TREATING ACNE AND PHOTO-AGEING BY TOPICAL SHORT-TERM TREATMENT WITH RETINOIDS
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US6048902A (en) 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6730308B1 (en) 1999-03-08 2004-05-04 Allergan, Inc. Tazarotene and alpha hydroxy acid treatment for psoriasis and/or photodamage
US6477410B1 (en) 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6495498B2 (en) 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities
US6524594B1 (en) 1999-06-23 2003-02-25 Johnson & Johnson Consumer Companies, Inc. Foaming oil gel compositions
US7074747B1 (en) 1999-07-01 2006-07-11 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
US6762158B2 (en) 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US20050009717A1 (en) 1999-07-01 2005-01-13 Lukenbach Elvin R. Foaming make-up removing cleansing compositions
US20030104041A1 (en) 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20030077301A1 (en) 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US20020119174A1 (en) 2000-07-26 2002-08-29 Gardlik John Michael Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
US20020035070A1 (en) 2000-07-26 2002-03-21 The Procter & Gamble Company Method of regulating hair growth using metal complexes of oxidized carbohydrates
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
FR2813189B1 (en) 2000-08-31 2003-02-28 Oreal COSMETIC FOAMING CREAM FOR THE TREATMENT OF OILY SKIN
US20030044432A1 (en) 2000-09-29 2003-03-06 Manetta Vincent E. Acne treating composition
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7060732B2 (en) 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20020193321A1 (en) 2000-12-12 2002-12-19 Mohan Vishnupad Dual dispenser for aesthitically acceptable delivery of anhydrous skin treatment compositions
US6495158B1 (en) 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
KR100861186B1 (en) 2001-03-26 2008-09-30 주식회사 엘지생활건강 Cosmetic for preventing and treating acnes containing Cryptotanshinone
US6428772B1 (en) 2001-06-25 2002-08-06 Blistex Inc. Acne treatment composition with cooling effect
EP1455888B1 (en) 2001-08-29 2009-04-29 PharmaKodex Limited Topical administration device
FR2829693B1 (en) 2001-09-20 2004-02-27 Oreal FOAMING COSMETIC CREAM
US20030064084A1 (en) 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
IL145751A (en) 2001-10-04 2010-12-30 Avi Dascalu Use of aluminum fluoride for the preparation of compositions for the treatment of acne vulgaris and folliculitis
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (en) 2001-12-21 2005-07-22 Galderma Res & Dev GEL COMPRISING AT LEAST ONE RETINOID AND BENZOYL PEROXIDE
US20040101566A1 (en) 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
US20030215493A1 (en) 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US20040043946A1 (en) 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US20060193789A1 (en) 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
GB0301577D0 (en) 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
US20040156873A1 (en) 2003-02-10 2004-08-12 Gupta Shyam K. Topically Bioavailable Acne and Rosacea Treatment Compositions
BRPI0407373B1 (en) 2003-02-12 2015-04-22 Stiefel Res Australia Pty Ltd Water Resistant Photoprotective Foaming and Foaming Composition
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
WO2005009342A2 (en) 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
CA2534372C (en) 2003-08-04 2012-01-24 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
JP2007503428A (en) 2003-08-25 2007-02-22 フォーミックス エルティーディー． Osmotic pharmaceutical foaming agent
JP4284200B2 (en) * 2004-01-28 2009-06-24 株式会社東芝 Nonvolatile semiconductor memory system
US20050255048A1 (en) 2004-05-15 2005-11-17 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
US20050276865A1 (en) 2004-05-20 2005-12-15 Servet Buyuktimkin Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
US9271902B2 (en) 2005-02-15 2016-03-01 Martin S. Giniger Whitening system capable of delivering effective whitening action
AR054805A1 (en) 2005-06-29 2007-07-18 Stiefel Laboratories TOPICAL COMPOSITIONS FOR SKIN TREATMENT
US9107844B2 (en) 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
MX2008012526A (en) * 2006-03-31 2008-10-14 Stiefel Res Australia Pyt Ltd Foamable suspension gel.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045662A2 (en) * 2000-12-06 2002-06-13 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20040073946A1 (en) * 2002-10-01 2004-04-15 Yoshikazu Kobayashi Terminal device, method for processing communication data inside the terminal device, and program for implementing the method
US20040151671A1 (en) * 2003-01-24 2004-08-05 Connetics Australia Pty Ltd. Pharmaceutical foam
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter

Also Published As

Publication number Publication date
EP2010133A4 (en) 2010-07-14
AR060234A1 (en) 2008-06-04
US8158109B2 (en) 2012-04-17
WO2008007224A2 (en) 2008-01-17
EP2206494B1 (en) 2015-12-02
AU2007273935A1 (en) 2008-01-17
US8758728B2 (en) 2014-06-24
PL2206494T3 (en) 2016-06-30
ES2582654T3 (en) 2016-09-14
AU2007273935B2 (en) 2011-08-18
EP2010133B1 (en) 2016-05-04
EP2206494A1 (en) 2010-07-14
TWI442944B (en) 2014-07-01
TW200744667A (en) 2007-12-16
US8475770B2 (en) 2013-07-02
US9265726B2 (en) 2016-02-23
US20140248220A1 (en) 2014-09-04
US20130280309A1 (en) 2013-10-24
CA2647127C (en) 2015-10-06
PL2010133T3 (en) 2017-08-31
US20110318278A1 (en) 2011-12-29
KR20090005102A (en) 2009-01-12
KR101368107B1 (en) 2014-03-14
ES2560540T3 (en) 2016-02-19
MX2008012526A (en) 2008-10-14
BRPI0709674A2 (en) 2011-12-06
CA2647127A1 (en) 2008-01-17
EP2010133A2 (en) 2009-01-07
US20070237724A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
WO2008007224A3 (en) Foamable suspension gel
TW200618821A (en) Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
WO2008057867A3 (en) Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
WO2006047788A3 (en) Methods and devices for sustained in-vivo release of an active agent
EP1995246A4 (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2007146227A3 (en) Flow-induced delivery from a drug mass
EP2352503A4 (en) Role of soluble upar in the pathogenesis of proteinuric kidney disease
IL217782A (en) Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2007089763A3 (en) Super soft foams
WO2006009987A3 (en) Dissolvable film composition
WO2009013435A3 (en) Preservative-free prostaglandin-based ophthalmic solution
WO2007041584A3 (en) Implantable sensors, implantable pumps, and anti-scarring drug combinations
MX268188B (en) Particulate water absorbing agent and method for production thereof, and water absorbing article.
WO2007019554A3 (en) Polysaccharides for delivery of active agents
WO2003030818A3 (en) Active agents using liposome beads
GB2421260A8 (en) Treatment agent absorbed on water insoluble particles
EP1965458A4 (en) Fuel cell system and mobile body
WO2005077334A8 (en) Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir
IL192053A (en) 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors and the use thereof in the preparation of medicaments
PL1879936T3 (en) Aqueous emulsion of alpha-silyl terminated polymers that is stable in storage, production of said emulsion and use of the latter
MX2009003455A (en) High alcohol-content foams.
TW200726468A (en) Gelled donepezil compositions and methods for making and using the same
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
PT2007347T (en) Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2007273935

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2007273935

Country of ref document: AU

Date of ref document: 20070329

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2647127

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/012526

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2192/MUMNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2007825280

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020087026472

Country of ref document: KR

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825280

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: PI0709674

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080929